ActivArmor wins $1.3M military grant and federal contract
DOD Award
ActivArmor, the leader in 3D protective casting and splinting protective solutions, announced its recent $1.3 million competitive SBIR direct-to-phase II grant award from the Defense Health Agency. This award will facilitate the deployment of ActivArmor systems to 11 military bases over 24 months, and enable all federal agencies to order the product, marking a significant milestone in their expansion strategy.
The non-dilutive funds acquired through this award will leverage investment dollars in ActivArmor's current capital raise, as the company accelerates its growth trajectory while delivering unparalleled value to its stakeholders.
Commercial Endorsement and Series A
On the commercial front, ActivArmor has successfully attracted investments from the venture capital community and continues to cultivate relationships with prospective partners. With plans underway for a South Eastern US pilot program and a surge in interest from distribution channels, ActivArmor is poised for rapid market penetration.
As ActivArmor advances toward its next growth phase, it seeks investment partners who share the vision for innovation and market leadership. With an esteemed advisory team, including a prominent NFL team physician, and overwhelming interest from distributors nationwide, the company is primed for accelerated market adoption.
ActivArmor's invitation for prospective investors to join them on their journey toward transformative growth is closing quickly, with stock being sold on a first-come-first-served basis.
"We are thrilled by the federal contract and momentum behind ActivArmor right now," said Diana Hall, CEO and Founder. "With the support of our partners and investors, we are poised for rapid expansion across both military and commercial sectors."
Investment Inquiries
For immediate inquiries regarding investment opportunities, please contact:
Diana Hall - diana.hall@activarmor.com
Gavin West - gavin.west@activarmor.com
